These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32218809)

  • 81. Rutin mediated targeting of signaling machinery in cancer cells.
    Perk AA; Shatynska-Mytsyk I; Gerçek YC; Boztaş K; Yazgan M; Fayyaz S; Farooqi AA
    Cancer Cell Int; 2014; 14(1):124. PubMed ID: 25493075
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Author Correction: Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape.
    Bruce JP; To KF; Lui VWY; Chung GTY; Chan YY; Tsang CM; Yip KY; Ma BBY; Woo JKS; Hui EP; Mak MKF; Lee SD; Chow C; Velapasamy S; Or YYY; Siu PK; El Ghamrasni S; Prokopec S; Wu M; Kwan JSH; Liu Y; Chan JYK; van Hasselt CA; Young LS; Dawson CW; Paterson IC; Yap LF; Tsao SW; Liu FF; Chan ATC; Pugh TJ; Lo KW
    Nat Commun; 2022 Jul; 13(1):4353. PubMed ID: 35896551
    [No Abstract]   [Full Text] [Related]  

  • 83. Prognostic Hypoxia-Angiogenesis-Related Gene Signature in Hepatocellular Carcinoma, in Which HILPDA Contributes to Tumor Progression.
    Wang S; Ye W; Yang K; Lv X; Luan J
    J Inflamm Res; 2024; 17():5663-5683. PubMed ID: 39219818
    [TBL] [Abstract][Full Text] [Related]  

  • 84. HPV16
    Konstantopoulos G; Leventakou D; Saltiel DR; Zervoudi E; Logotheti E; Pettas S; Karagianni K; Daiou A; Hatzistergos KE; Dafou D; Arsenakis M; Kottaridi C
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38257813
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A novel prognostic biomarker:
    Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J
    Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Tumor Budding Is an Independent Prognostic Factor in Pancreatic Adenocarcinoma and It Positively Correlates with PD-L1 Expression on Tumor Cells.
    Pęksa R; Kunc M; Czapiewski P; Piątek M; Hać S; Radecka B; Biernat W
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885065
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis.
    Guo CL
    Front Cell Dev Biol; 2022; 10():862791. PubMed ID: 35774228
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape.
    Wu Q; You L; Nepovimova E; Heger Z; Wu W; Kuca K; Adam V
    J Hematol Oncol; 2022 Jun; 15(1):77. PubMed ID: 35659268
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment.
    Lappano R; Todd LA; Stanic M; Cai Q; Maggiolini M; Marincola F; Pietrobon V
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158804
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients.
    Lv W; Yao Q
    Dis Markers; 2022; 2022():9428660. PubMed ID: 35069936
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Melatonin and hyperbaric oxygen therapies suppress colorectal carcinogenesis through pleiotropic effects and multifaceted mechanisms.
    Li YC; Chen CH; Chang CL; Chiang JY; Chu CH; Chen HH; Yip HK
    Int J Biol Sci; 2021; 17(14):3728-3744. PubMed ID: 34671196
    [TBL] [Abstract][Full Text] [Related]  

  • 92.
    Lam M; Reales-Calderon JA; Ow JR; Adriani G; Pavesi A
    APL Bioeng; 2021 Dec; 5(4):041502. PubMed ID: 34632251
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells.
    Sukowati CHC; El-Khobar KE; Tiribelli C
    World J Stem Cells; 2021 Jul; 13(7):795-824. PubMed ID: 34367478
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Anticipating metastasis through electrochemical immunosensing of tumor hypoxia biomarkers.
    Muñoz-San Martín C; Gamella M; Pedrero M; Montero-Calle A; Pérez-Ginés V; Camps J; Arenas M; Barderas R; Pingarrón JM; Campuzano S
    Anal Bioanal Chem; 2022 Jan; 414(1):399-412. PubMed ID: 33635388
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Regulation of PD-L1: a novel role of pro-survival signalling in cancer.
    Chen J; Jiang CC; Jin L; Zhang XD
    Ann Oncol; 2016 Mar; 27(3):409-16. PubMed ID: 26681673
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1.
    Tai YT; Cho SF; Anderson KC
    Front Immunol; 2018; 9():1822. PubMed ID: 30147691
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.
    Barsoum IB; Smallwood CA; Siemens DR; Graham CH
    Cancer Res; 2014 Feb; 74(3):665-74. PubMed ID: 24336068
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
    Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
    Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Role and mechanism of programmed death-ligand 1 in hypoxia-induced liver cancer immune escape.
    Wen Q; Han T; Wang Z; Jiang S
    Oncol Lett; 2020 Apr; 19(4):2595-2601. PubMed ID: 32218809
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.